|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.8001 USD | -5.79% |
|
-18.17% | -27.92% |
Company Valuation: Celularity Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | - | 632.1 | 187.1 | 47.24 | 46.77 | 31.61 |
| Change | - | - | -70.41% | -74.75% | -1% | -32.41% |
| Enterprise Value (EV) 1 | - | 626 | 238.7 | 112.4 | 114.9 | 100.1 |
| Change | - | - | -61.87% | -52.9% | 2.17% | -12.81% |
| P/E | -1.27x | -3.43x | 14.3x | -0.22x | -0.79x | -0.31x |
| PBR | -4.97x | 6.4x | 0.97x | 1.17x | 5.31x | -0.84x |
| PEG | - | 0x | -0x | 0x | 0x | -0x |
| Capitalization / Revenue | - | 29.6x | 10.4x | 2.07x | 0.86x | 1.19x |
| EV / Revenue | - | 29.3x | 13.3x | 4.94x | 2.12x | 3.77x |
| EV / EBITDA | - | -4.86x | -1.72x | -1.67x | -3.75x | -1.85x |
| EV / EBIT | - | -4.55x | -1.61x | -1.47x | -2.98x | -1.69x |
| EV / FCF | - | -12.5x | -3.46x | -4.74x | 11.1x | 18.6x |
| FCF Yield | - | -7.97% | -28.9% | -21.1% | 8.99% | 5.38% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -86.9 | -14.93 | 0.9 | -11.02 | -2.645 | -3.586 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 14.28 | 21.34 | 17.98 | 22.77 | 54.22 | 26.55 |
| EBITDA 1 | -69.92 | -128.9 | -138.8 | -67.16 | -30.63 | -54.01 |
| EBIT 1 | -78.09 | -137.7 | -148.3 | -76.48 | -38.55 | -59.4 |
| Net income 1 | -208.2 | -100.1 | 14.19 | -196.3 | -57.89 | -91.72 |
| Net Debt 1 | -23.67 | -6.104 | 51.62 | 65.19 | 68.1 | 68.54 |
| Reference price 2 | 110.0000 | 51.2000 | 12.9000 | 2.4740 | 2.0800 | 1.1100 |
| Nbr of stocks (in thousands) | - | 12,346 | 14,501 | 19,095 | 22,484 | 28,479 |
| Announcement Date | 3/29/21 | 3/31/22 | 3/31/23 | 7/30/24 | 5/8/25 | 4/30/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 25.96M | |
| 41.42x | 14.04x | 31.11x | 0.48% | 1,263B | |
| 39.99x | 6.71x | 18.89x | 1.95% | 658B | |
| 36.71x | 8.6x | 17.71x | 2.33% | 521B | |
| 21.74x | 5.27x | 13.12x | 2.48% | 391B | |
| 106.24x | 6.06x | 25.8x | 2.28% | 369B | |
| 23.19x | 5.95x | 14.36x | 2.69% | 307B | |
| 24.47x | 4.89x | 13.59x | 1.77% | 290B | |
| 29.55x | 7.53x | 13.48x | 2.16% | 252B | |
| -41.18x | 7.46x | 46.76x | 1.93% | 212B | |
| Average | 31.35x | 7.39x | 21.65x | 2.01% | 426.2B | |
| Weighted average by Cap. | 37.16x | 8.83x | 22.81x | 1.69% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CELU Stock
- Valuation Celularity Inc.
Select your edition
All financial news and data tailored to specific country editions
